Price $169.07 |
Market Cap
21.84B
|
Sector Capital Goods |
Div. Growth
15.20%
|
|
P/E
15.0
|
P/B
3.61
|
P/S
1.5
|
Dividend %
2.10%
|
|
P/CF
-
|
P/FCF
18.8
|
Op. Cash Flow
1.79M
|
FCF
8.9
|
|
Op. Margin
13.30%
|
Net Margin
10.00%
|
ROE
24.40%
|
ROI
13.30%
|
|
ROA
9.40%
|
EPS Growth
47.50%
|
Current Ratio
1.6
|
Debt/Equity
73.70%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Cross Country Healthcare, Inc. (CCRN) | $9.15 | - | - | 327.8M | Strong Buy |
| Innovative Solutions & Support (ISSC) | $4.59 | - | - | 76.9M | Strong Buy |
| Inphi Corporation (IPHI) | $58.75 | - | - | 2.23B | Strong Buy |
| Interpace Diagnostics Group In (IDXG) | $0.70 | - | - | 28.2M | Strong Buy |
| IZEA Worldwide Inc (IZEA) | $0.52 | - | - | 15.5M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
